BHC - CIK 0000885590
Bausch Health Companies Inc. (BHC) reported revenue of $10.27B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $10.27B | +6.7% |
| FY 2024 | $9.63B | +9.9% |
| FY 2023 | $8.76B | +7.8% |
| FY 2022 | $8.12B | -3.7% |
| FY 2021 | $8.43B | +5.1% |
| FY 2020 | $8.03B | -6.7% |
| FY 2019 | $8.60B | +2.6% |
| FY 2018 | $8.38B | -3.9% |
| FY 2017 |
Bausch Health Companies Inc. (BHC) reported revenue of $10.27B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, Bausch Health Companies Inc.'s revenue grew from $2.43B to $10.27B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $8.72B |
| -9.8% |
| FY 2016 | $9.67B | -7.4% |
| FY 2015 | $10.45B | +27.3% |
| FY 2014 | $8.21B | +42.2% |
| FY 2013 | $5.77B | +65.8% |
| FY 2012 | $3.48B | +43.4% |
| FY 2011 | $2.43B | - |